Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry

Elena Laakmann; Isabell Witzel; Tanja Neunhöffer; Tjoung‐Won Park‐Simon; Rudolf Weide; Kerstin Riecke; A Polasik; Marcus Schmidt; Julian Puppe; Christoph Mundhenke; Kristina Lübbe; Tobias Hesse; Marc Thill; D.-M. Zahm; Carsten Denkert; Tanja Fehm; Valentina Nekljudova; Julia Rey; Sibylle Loibl; Volkmar Müller

doi:10.1016/j.esmoop.2022.100495

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

We identified factors associated with the prognosis of HER2-positive patients with BMs. Further research is needed to understand the factors determining the longer survival of HER2-positive/hormone receptor-positive patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Laakmann et al. (2022) studied this question.

synapsesocial.com/papers/69dd67f87dbdc4ad1440c8c0 https://doi.org/10.1016/j.esmoop.2022.100495

View Full Paper

Ask AI

Bookmark

Share

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry

Ask about this paper

Abstract

Discussion

Cite This Study

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading